Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |